Suppr超能文献

[新喀里多尼亚(南太平洋)1973 - 1991年皮肤恶性黑色素瘤。97例研究]

[Cutaneous malignant melanoma in New Caledonia (South Pacific) 1973-1991. A study of 97 cases].

作者信息

Huerre M, Dubourdieu D, Ravisse P, Prade M, McCarthy S W, Floch J J, Michel G, Monchy D, Baudin R, Herrmann M

机构信息

Laboratoire d'anatomie pathologique, Institut Pasteur, Nouvelle-Calédonie, France.

出版信息

Bull Cancer. 1993 Mar;80(3):235-47.

PMID:8173176
Abstract

The Cancer Registries have been operational in the South Pacific since 1958 (Papua New Guinea), Fiji (1965) and New Caledonia (1977) and complete cancer incidence rates are available, based on histologic data. We studied 97 melanomas, histologically confirmed, which were diagnosed in New Caledonia from 1973 to 1991. New Caledonia is located in the same latitude as Queensland in Australia, known for having the highest incidence of melanoma in the world. Standardised incidence rates (world population) were 9.82 and 7.65/100,000/year for European males and females, compared to 1.65 and 1.05 for Melanesian and Polynesian males and females. The European population is exposed and Melanesians/Polynesians are relatively protected as are black Americans or Africans. The mixed populations are protected, but no study is available as to the exact proportion of mixed people (20%?) in the entire population. For Europeans, among males, the main areas in which melanomas occur are the trunk (45%) the arm (13%) and the leg (13%). Among females, the main areas are the leg (27%), the trunk (20%) and the head (18%). Screening for melanoma has been more effective in the last 6 years, a period in which we diagnosed half the total cases and generally at earlier stages. Prognosis was poor for this period (1973-1991): the five year survival rates were 64% +/- 8%, not as good as in Europe or Australia, but these lesions were diagnosed between 1973 and 1985 and were generally more invasive. A better prognosis will probably be observed in a few years, and another evaluation of melanoma screening should be made in the future as well the study of precursors and early lesions.

摘要

自1958年起(巴布亚新几内亚)、1965年起(斐济)以及1977年起(新喀里多尼亚),癌症登记处在南太平洋地区开始运作,基于组织学数据可获取完整的癌症发病率。我们研究了97例经组织学确诊的黑色素瘤病例,这些病例于1973年至1991年在新喀里多尼亚被诊断出来。新喀里多尼亚与澳大利亚的昆士兰州处于同一纬度,昆士兰州以全球黑色素瘤发病率最高而闻名。欧洲男性和女性的标准化发病率(世界人口)分别为每年9.82和7.65/10万,而美拉尼西亚和波利尼西亚男性和女性的标准化发病率分别为1.65和1.05。欧洲人群易患黑色素瘤,而美拉尼西亚人/波利尼西亚人相对不易患病,就像美国黑人或非洲人一样。混血人群也不易患病,但目前尚无关于混血人群在整个人口中的确切比例(20%?)的研究。对于欧洲人来说,男性黑色素瘤主要发生在躯干(45%)、手臂(13%)和腿部(13%)。女性则主要发生在腿部(27%)、躯干(20%)和头部(18%)。在过去6年中,黑色素瘤筛查更为有效,在此期间我们诊断出了总病例数的一半,且通常处于早期阶段。这一时期(1973 - 1991年)的预后较差:五年生存率为64%±8%,不如欧洲或澳大利亚,但这些病变是在1973年至1985年期间被诊断出来的,通常具有更强的侵袭性。几年后可能会观察到更好的预后,未来还应再次评估黑色素瘤筛查情况以及对癌前病变和早期病变进行研究。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验